Ceftriaxone-associated biliary pseudolithiasis.
Rienstra
M
M
Department of Internal Medicine, Meander Medical Centre, Amersfoort, the Netherlands. M.Rienstra@meandermc.nl
Bonten
M J M
MJ
Gaillard
C A J M
CA
D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D002443:Ceftriaxone / Q000009:adverse effects*; D041761:Cholecystolithiasis / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged
D000900:Anti-Bacterial Agents; D002443:Ceftriaxone